Agena, DaRui Biotechnology announces China FDA clearance of MassArray Technology

Agena Bioscience (Agena), a San-Diego-based develops, manufactures, and supplies genetic analysis systems and reage...

October 25, 2018 | Thursday | News
Reistone Biopharma to intiate Ph 2 clinical trial of Ulcerative Colitis globally

Reistone Biopharma Company Limited, a clinical stage biopharmaceutical company headquartered in Shanghai has announced&...

October 23, 2018 | Tuesday | News
Cancer Genetics partners with Genecast Biotechnology

Cancer Genetics, Inc., a leader in enabling precision medicine for immuno-oncology and genomics through molecular marker...

October 20, 2018 | Saturday | News
Chi-Med Initiates a Ph I Trial of HMPL-523 for AML

Hutchison China MediTech Limited (Chi-Med) has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase (...

October 19, 2018 | Friday | News
Pharma firm to pay $1.3B fine for vaccine scandal

Changchun Changsheng Life Sciences Ltd has been charged with a huge fine of $1.3 billion for falsifying production recor...

October 17, 2018 | Wednesday | News
JHL Biotech receives China approval for cancer Biosimilar

JHL Biotech announced that the National Medical Products Administration of the PRC (NMPA) has approved JHL's Phase I and...

October 16, 2018 | Tuesday | News
Curetis, Beijing Clear Biotech expand strategic collaboration

Curetis, a developer of next-level molecular diagnostic solutions, has announced that it has significantly expanded its ...

October 16, 2018 | Tuesday | News
MEI Pharma, BeiGene to co-develop cancer drug

MEI Pharma, a late-stage pharmaceutical company focused on advancing new therapies for cancer and BeiGene, a commer...

October 12, 2018 | Friday | News
Rgenix raises $40 M in series C funding

Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer th...

October 12, 2018 | Friday | News
UniCAR teams up with Terumo BCT to improve CAR T-cell therapies

Shanghai UniCAR-Therapy Bio-Medicine Technology Co. chose Terumo BCT and its cell expansion devices to automate its cell...

October 11, 2018 | Thursday | News
Jinxin Fertility announces completion of major financing round

With a potential market size of more than RMB100 billion, assisted reproduction has become one of the fastest growing ma...

October 10, 2018 | Wednesday | News
PolyU team develops new system for elderly care

The Hong Kong Polytechnic University (PolyU) has developed eNightLog, a multi-function nighttime monitoring system for e...

October 10, 2018 | Wednesday | News
Yisheng receives approval for rabies vaccine clinical study

Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and mar...

October 10, 2018 | Wednesday | News
AI based healthcare startup raises $15M funding

Deep Intelligent Pharma, a healthcare AI start-up providing new drug research and development services for pharmaceutica...

October 9, 2018 | Tuesday | News
CASI Pharmaceuticals appoints new president for China Operations

CASI Pharmaceuticals, a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effect...

October 8, 2018 | Monday | News
Cellular Bio gets NCI patent license for solid tumour immunotherapy

Cellular Biomedicine Group Inc. (CBMG), a clinical-stage biopharmaceutical firm engaged in the development of immunother...

October 5, 2018 | Friday | News
AXA Hong Kong, HKSH medical group enter into collaboration

AXA Hong Kong and HKSH Medical Group has entered into collaboration under which HKSH will be the first and biggest partn...

October 4, 2018 | Thursday | News
Hong Kong Department of Health approves Biktarvy

Singapore - Gilead Sciences announced that the Hong Kong Department of Health has approved Biktarvy (bictegravir 50mg/em...

October 3, 2018 | Wednesday | News